BCR-ABL-IN-11
BCR-ABL-IN-11 (Compound 2) is a BCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous leukemia (CML) (IC50 of 129.61 μM for K562 cells).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2362-25-6
- Formule: C20H18N4O2
- Masse moléculaire:346.38
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| K562 | IC50 |
129.61 μM
Compound: 2
|
Inhibitory activity against human K562 cells growth using MTT assay
Inhibitory activity against human K562 cells growth using MTT assay
|
[PMID: 14552760] |
Chemical Information
-
CAS No. 2362-25-6
-
Masse moléculaire 346.38
-
Formule C20H18N4O2
-
SMILES
O=C(C1=CC=C(C=C1)N)NC2=CC=CC(NC(C3=CC=C(C=C3)N)=O)=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)